Status:
UNKNOWN
Morton's Neuroma: Manipulation Versus Steroid Injection
Lead Sponsor:
Queen Margaret University
Conditions:
Neuroma, Human Forefoot
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to establish which of two treatment options is the preferred intervention in the treatment of Morton's Neuroma. A randomised controlled trial shall be performed. Steroid inje...
Detailed Description
Proposed Randomised Single Blind Study Aims and objectives The aim of this study is to establish which of two treatment options is the preferred intervention in the treatment of Morton's Neuroma. Obj...
Eligibility Criteria
Inclusion
- Inclusion criteria shall be any positive clinical sign together with a positive diagnostic ultrasound giving rise to a diagnosis of Morton's neuroma/plantar digital neuritis.
- A VAS score of no less than 25/100 will also be required.
- All subjects must be over 18 years of age and able to offer informed consent.
Exclusion
- Absolute exclusion criteria will include Rheumatoid Arthritis, recent (less than 3 months) fracture to the affected foot, peripheral neuropathy, localised infection, pregnancy, allergy to Methylprednisolone.
- Allergy to local anaesthetic.
- Further exclusion criteria include Active infection
- Diabetes mellitus
- Ulcerative colitis
- Diverticulitis
- Hypothyroidism
- Osteoporosis
- Renal impairment
- Hepatic impairment and Coagulation disorders.
Key Trial Info
Start Date :
October 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2017
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT02304094
Start Date
October 1 2015
End Date
April 1 2017
Last Update
March 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Margaret University
Musselburgh, Lothian, United Kingdom, EH21 6UU